CHD1Li 6.11 structure
|
Common Name | CHD1Li 6.11 | ||
|---|---|---|---|---|
| CAS Number | 2716890-91-2 | Molecular Weight | 472.40 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H22BrN5OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CHD1Li 6.11CHD1Li 6.11 is a potent oncogenic CHD1L inhibitor (IC50=3.3 µM for cat-CHD1L recombinant protein). CHD1Li 6.11 is an orally bioavailable antitumor agent, significantly reducing the tumor volume of CRC xenografts generated from isolated quasi mesenchymal cells (M-phenotype), which possess enhanced tumorigenic properties[1]. |
| Name | CHD1Li 6.11 |
|---|
| Description | CHD1Li 6.11 is a potent oncogenic CHD1L inhibitor (IC50=3.3 µM for cat-CHD1L recombinant protein). CHD1Li 6.11 is an orally bioavailable antitumor agent, significantly reducing the tumor volume of CRC xenografts generated from isolated quasi mesenchymal cells (M-phenotype), which possess enhanced tumorigenic properties[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C21H22BrN5OS |
|---|---|
| Molecular Weight | 472.40 |
| InChIKey | ACDZBXZERLBYOW-UHFFFAOYSA-N |
| SMILES | Cc1cc(Nc2ccc(NC(=O)Cc3cc(Br)cs3)cc2)nc(N2CCCC2)n1 |